Laryngeal cancer other imaging findings: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Laryngeal cancer}} | {{Laryngeal cancer}} | ||
{{CMG}} {{AE}}{{Faizan}} | {{CMG}} {{AE}} {{OK}}, {{Faizan}} | ||
==Overview== | ==Overview== | ||
| Line 7: | Line 7: | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
Other imaging findings for [[laryngeal cancer]] inlcude: | Other imaging findings for [[laryngeal cancer]] inlcude:<ref name="pmid21674668">{{cite journal |vauthors=Rudmik L, Lau HY, Matthews TW, Bosch JD, Kloiber R, Molnar CP, Dort JC |title=Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial |journal=Head Neck |volume=33 |issue=7 |pages=935–40 |date=July 2011 |pmid=21674668 |doi=10.1002/hed.21566 |url=}}</ref><ref name="pmid18023031">{{cite journal |vauthors=Johansen J, Buus S, Loft A, Keiding S, Overgaard M, Hansen HS, Grau C, Bundgaard T, Kirkegaard J, Overgaard J |title=Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study |journal=Head Neck |volume=30 |issue=4 |pages=471–8 |date=April 2008 |pmid=18023031 |doi=10.1002/hed.20734 |url=}}</ref> | ||
Fluoro-D-glucose [[positron emission tomography]] [[PET]] which is taken up more by actively [[metabolic]] cells | Fluoro-D-glucose [[positron emission tomography]] [[PET]] which is taken up more by actively [[metabolic]] cells | ||
Revision as of 22:37, 10 January 2019
|
Laryngeal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Laryngeal cancer other imaging findings On the Web |
|
American Roentgen Ray Society Images of Laryngeal cancer other imaging findings |
|
Risk calculators and risk factors for Laryngeal cancer other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2], Faizan Sheraz, M.D. [3]
Overview
Other imaging findings for laryngeal cancer inlcude Fluoro-D-glucose positron emission tomography PET which is taken up more by actively metabolic cells. In case of small glottic tumors further imaging may be unnecessary. Laryngoscopy can be helpful to visualize the tumor.
Other Imaging Findings
Other imaging findings for laryngeal cancer inlcude:[1][2]
Fluoro-D-glucose positron emission tomography PET which is taken up more by actively metabolic cells
Laryngoscopy
In case of small glottic tumors further imaging may be unnecessary. Laryngoscopy can be helpful to visualize the tumor.
References
- ↑ Rudmik L, Lau HY, Matthews TW, Bosch JD, Kloiber R, Molnar CP, Dort JC (July 2011). "Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial". Head Neck. 33 (7): 935–40. doi:10.1002/hed.21566. PMID 21674668.
- ↑ Johansen J, Buus S, Loft A, Keiding S, Overgaard M, Hansen HS, Grau C, Bundgaard T, Kirkegaard J, Overgaard J (April 2008). "Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study". Head Neck. 30 (4): 471–8. doi:10.1002/hed.20734. PMID 18023031.